Kidney Transplantation in Children: The Preferred Option But Still No Cure

American Journal of Kidney Diseases

Volumn 51, Issue 6, 2008, Pages 880-881

  Craig, Jonathan C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; CHRONIC KIDNEY DISEASE; DIALYSIS; DISEASE COURSE; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY;

CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION;

EID: 43849093121     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.04.009     Document Type: Editorial

References (17)

1. White C.T., Schisler T., Lee E., Djurdjev O., and Matsuda-Abedini M. CKD following kidney transplantation in children and adolescents. Am J Kidney Dis 51 (2008) 996-1004
2. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 suppl 1 (2002) S14-S266
3. McDonald S., and Craig J.C. Long-term survival of children with end-stage renal disease. N Engl J Med 350 (2004) 29-37
4. Chacko B., Rajamanickam T., Neelakantan N., Tamilarasi V., and John G.T. Pediatric renal transplantation-a single center experience of 15 yr from India. Pediatr Transplant 11 (2007) 844-849
5. Magee J.C., Bucuvalas J.C., Farmer D.G., Harmon W.E., Hulbert-Shearon T.E., and Mendeloff E.N. Pediatric transplantation. Am J Transplant 9 suppl 9 (2004) 54-71
6. Groothoff J.W., Gruppen M.P., Offringa M., et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61 (2002) 621-629
7. Sarwal M., and Pascual J. Immunosuppression minimization in pediatric transplantation. Am J Transplant 7 (2007) 2227-2235
8. Webster A.C., Woodroffe R.C., Taylor R.S., Chapman J.R., and Craig J.C. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: a meta-analysis and meta-regression of randomised trial data. BMJ 331 (2005) 810-814
9. Webster A., Lee V.W.S., Chapman J.R., and Craig J.C. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomised trials. Transplantation 81 (2006) 1234-1248
10. Phrommintikul A., Haas S.J., Elsik M., and Klum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369 (2007) 381-388
11. Strippoli G.F., Tognoni G., Navaneethan S.D., Nicolucci A., and Craig J.C. Haemoglobin targets: we were wrong, time to move on. Lancet 369 (2007) 346-350
12. Neal B., MacMahon S., Chapman N., and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 356 (2000) 1955-1964
13. Wiysonge C.S., Bradley H., Mayosi B.M., et al. Beta-blockers for hypertension. Cochrane Database of Systematic Reviews (2007) (1):CD002003
14. Palmer S.C., McGregor D.O., Macaskill P., Craig J.C., Elder G.J., and Strippoli G.F. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147 (2007) 840-853
15. Strippoli G.F.M., Palmer S., Tong A., Elder G., Messa P., and Craig J.C. Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 47 (2006) 715-726
16. Rodrigo E., Fernandez-Fresnedo G., Valero R., et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 17 suppl 3 (2006) S291-S295
17. Pham P.T., Pham P.C., Lipshutz G.S., and Wilkinson A.H. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 36 (2007) 873-890